Recently, APEX1 is recognized as a potential diagnostic biomarker in various cancers, such as renal carcinoma, hepatobiliary carcinomas, cholangiocarcinoma, non‐small‐cell lung cancer, etc.8–10,32. The gene discussed is APEX1; the disease is cholangiocarcinoma.